Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | https://onlinelibrary.wiley.com/doi/10.1111/php.13970 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1867016232512782336 |
|---|---|
| author | Idrisa Rahman Barry Liang Andaleeb Sajid Suresh V. Ambudkar Huang‐Chiao Huang |
| author_facet | Idrisa Rahman Barry Liang Andaleeb Sajid Suresh V. Ambudkar Huang‐Chiao Huang Idrisa Rahman Barry Liang Andaleeb Sajid Suresh V. Ambudkar Huang‐Chiao Huang |
| collection | Wiley Open Access |
| contents | Photodynamic priming modulates cellular ATP levels to overcome P‐glycoprotein‐mediated drug efflux in chemoresistant triple‐negative breast cancer Idrisa Rahman Barry Liang Andaleeb Sajid Suresh V. Ambudkar Huang‐Chiao Huang Photochemistry and Photobiology AbstractP‐glycoprotein (P‐gp, ABCB1) is a well‐researched ATP‐binding cassette (ABC) drug efflux transporter linked to the development of cancer multidrug resistance (MDR). Despite extensive studies, approved therapies to safely inhibit P‐gp in clinical settings are lacking, necessitating innovative strategies beyond conventional inhibitors or antibodies to reverse MDR. Photodynamic therapy is a globally approved cancer treatment that uses targeted, harmless red light to activate non‐toxic photosensitizers, confining its cytotoxic photochemical effects to disease sites while sparing healthy tissues. This study demonstrates that photodynamic priming (PDP), a sub‐cytotoxic photodynamic therapy process, can inhibit P‐gp function by modulating cellular respiration and ATP levels in light accessible regions. Using chemoresistant (VBL‐MDA‐MB‐231) and chemosensitive (MDA‐MB‐231) triple‐negative breast cancer cell lines, we showed that PDP decreases mitochondrial membrane potential by 54.4% ± 30.4 and reduces mitochondrial ATP production rates by 94.9% ± 3.46. Flow cytometry studies showed PDP can effectively improve the retention of P‐gp substrates (calcein) by up to 228.4% ± 156.3 in chemoresistant VBL‐MDA‐MB‐231 cells, but not in chemosensitive MDA‐MB‐231 cells. Further analysis revealed that PDP did not alter the cell surface expression level of P‐gp in VBL‐MDA‐MB‐231 cells. These findings indicate that PDP can reduce cellular ATP below the levels that is required for the function of P‐gp and improve intracellular substrate retention. We propose that PDP in combination with chemotherapy drugs, might improve the efficacy of chemotherapy and overcome cancer MDR. 10.1111/php.13970 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| doi_str_mv | 10.1111/php.13970 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_php_13970 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Photodynamic priming modulates cellular ATP levels to overcome P‐glycoprotein‐mediated drug efflux in chemoresistant triple‐negative breast cancer Idrisa Rahman Barry Liang Andaleeb Sajid Suresh V. Ambudkar Huang‐Chiao Huang Photochemistry and Photobiology Photodynamic priming modulates cellular ATP levels to overcome P‐glycoprotein‐mediated drug efflux in chemoresistant triple‐negative breast cancer Idrisa Rahman Barry Liang Andaleeb Sajid Suresh V. Ambudkar Huang‐Chiao Huang Photochemistry and Photobiology AbstractP‐glycoprotein (P‐gp, ABCB1) is a well‐researched ATP‐binding cassette (ABC) drug efflux transporter linked to the development of cancer multidrug resistance (MDR). Despite extensive studies, approved therapies to safely inhibit P‐gp in clinical settings are lacking, necessitating innovative strategies beyond conventional inhibitors or antibodies to reverse MDR. Photodynamic therapy is a globally approved cancer treatment that uses targeted, harmless red light to activate non‐toxic photosensitizers, confining its cytotoxic photochemical effects to disease sites while sparing healthy tissues. This study demonstrates that photodynamic priming (PDP), a sub‐cytotoxic photodynamic therapy process, can inhibit P‐gp function by modulating cellular respiration and ATP levels in light accessible regions. Using chemoresistant (VBL‐MDA‐MB‐231) and chemosensitive (MDA‐MB‐231) triple‐negative breast cancer cell lines, we showed that PDP decreases mitochondrial membrane potential by 54.4% ± 30.4 and reduces mitochondrial ATP production rates by 94.9% ± 3.46. Flow cytometry studies showed PDP can effectively improve the retention of P‐gp substrates (calcein) by up to 228.4% ± 156.3 in chemoresistant VBL‐MDA‐MB‐231 cells, but not in chemosensitive MDA‐MB‐231 cells. Further analysis revealed that PDP did not alter the cell surface expression level of P‐gp in VBL‐MDA‐MB‐231 cells. These findings indicate that PDP can reduce cellular ATP below the levels that is required for the function of P‐gp and improve intracellular substrate retention. We propose that PDP in combination with chemotherapy drugs, might improve the efficacy of chemotherapy and overcome cancer MDR. 10.1111/php.13970 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| title | Photodynamic priming modulates cellular ATP levels to overcome P‐glycoprotein‐mediated drug efflux in chemoresistant triple‐negative breast cancer |
| topic | Photochemistry and Photobiology |
| url | https://onlinelibrary.wiley.com/doi/10.1111/php.13970 |